Arguments over a complaint filed in the Circuit Court for the City of Norfolk, Virginia, were presented today to decide if patients of one of the world’s most published critical care physicians can be given lifesaving treatments for COVID-19 that a local hospital system has prohibited.
Ivermectin is used to fight worms and other parasites in animals and humans. But some people are taking it to treat COVID-19, despite warnings from experts and poisonings tied to the drug.
The FLCCC Alliance to host program with special guests, including patients & their families who’ve fought legal battles to get access to life-saving treatments for COVID
Rutgers Professor Lewis Nelson is available to discuss the dangers of people taking the livestock deworming drug ivermectin to try to treat COVID-19. Demand for the drug is surging nationwide despite warnings from the Food and Drug Administration and the…
The Front Line COVID-19 Critical Care Alliance (FLCCC), a group of highly published, world-renowned critical care physicians and scholars, and the British Ivermectin Recommendation Development Group (BIRD), a U.K. based group of medical and scientific experts from over 15 countries, are concerned over the misrepresentation of science in the recent article published in the Guardian regarding the withdrawal of Professor Emeritus Ahmed Elgazzar’s study into ivermectin that was first posted December 16, 2020.
FLCCC Alliance calls for whistleblower to step forward from within WHO, the FDA, the NIH, Merck, or Unitaid to counter this misrepresentation
After COVID-19 emerged on U.S shores, providers began reviewing the emerging basic science, translational, and clinical data to identify potentially effective treatment options. In addition, a multitude of both novel and repurposed therapeutic agents were used empirically and studied within clinical trials.
WHO ignores significant data, including several large clinical trials, while claiming insufficient evidence to recommend the use of ivermectin to prevent and treat COVID-19
Front Line COVID-19 Critical Care Alliance to Convene Global Panel of Leading Experts to Discuss the Latest Research on Preventing and Treating COVID-19 with Ivermectin
FLCCC Alliance’s response to the University of Oxford’s planned ivermectin Randomized Controlled Trial.
The Front Line COVID-19 Critical Care Alliance (FLCCC) has issued a public response to the National Institutes of Health (NIH) regarding the NIH COVID-19 Treatment Guidelines Panel’s “neither for nor against” recommendation for the use of ivermectin in the treatment of COVID-19.
NIH Revises Treatment Guidelines for Ivermectin for the Treatment of COVID-19 Ivermectin is Now a Therapeutic Option for Doctors & Prescribers
The Critical Care physicians of the Front Line COVID-19 Critical Care Alliance (FLCCC) have announced an immediate update to the dosing strategy of their I-Mask+ Protocol for the prevention and treatment of COVID-19.
FLCCC Urges Review of Current Data and an Updated NIH Guidance
“It will all be needless death from here on out, given that there is a readily available scientific solution to the pandemic,” Kory says.